HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

9th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain

Actinomyces Israelii

Actinomyces Israelii

Actinomyces israelii is a filamentous, Gram-positive bacterium that is a prominent member of the Actinomyces genus. This bacterium is well-known for its role in causing actinomycosis, a chronic and often indolent infection that can affect various body tissues. Actinomyces israelii is a commensal in the oral cavity and gastrointestinal tract, but it can become pathogenic under certain conditions. Actinomyces israelii infections typically present as cervicofacial actinomycosis, characterized by the formation of abscesses, draining sinuses, and the development of sulfur granules. These sulfur granules, consisting of bacterial colonies and debris, are a hallmark feature of actinomycosis. Diagnosis involves clinical evaluation, imaging studies, and often the identification of sulfur granules in aspirated material. The treatment of Actinomyces israelii infections generally requires prolonged antibiotic therapy, with penicillin being the drug of choice. Surgical drainage or excision may be necessary for extensive abscesses. While actinomycosis caused by Actinomyces israelii can be challenging to diagnose and manage, prompt and appropriate intervention can lead to favorable outcomes.

Submit your abstract Today

Watsapp